A novel treatment uniquely and selectively binds critical metals to interrupt enzyme function, returning cellular metals like Iron, copper, and zinc to homeostasis and turning off the underlying cause of cancer development and growth.
By targeting specific classes of enzymes through its metal binding properties, Telomir 1 is believed to selectively affect the key processes that drive the concentration and accumulation of iron and copper in the serum that affects diseases like hemochromatosis and cancer.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 900 W Platt St,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://telomirpharma.com/
- Keywords
- sunny isles beach.
- HQ
- Tampa, Florida
Telomir Pharmaceuticals, Inc. Questions
Telomir Pharmaceuticals, Inc.'s website is https://telomirpharma.com/
Telomir Pharmaceuticals, Inc.'s LinkedIn profile is https://www.linkedin.com/company/telomir-pharmaceuticals-inc
Telomir Pharmaceuticals, Inc. has
6 employees.
View email and phone details for 6
employees at Telomir Pharmaceuticals, Inc..
Telomir Pharmaceuticals, Inc.'s industry is
Biotechnology Research
Telomir Pharmaceuticals, Inc.'s top competitors are
Kailera Therapeutics,
Tnf Pharmaceuticals, Inc.,
Cincor Pharma, Inc.,
Locate Venture Corp.,
Sino Biopharmaceutical Limited,
Mira Pharmaceuticals,
Lanova Medicines,
Biocon,
Nicox,
Hengrui Pharma.
Telomir Pharmaceuticals, Inc.'s categories are Biotechnology Research
Telomir Pharmaceuticals, Inc.'s founding year is 2022
